Liu G - Search Results

1

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients.

You C, Peng W, Zhi W, He M, Liu G, Xie L, Jiang L, Hu X, Shen X, Gu Y. You C, et al. Among authors: liu g. Transl Oncol. 2017 Oct;10(5):786-792. doi: 10.1016/j.tranon.2017.07.005. Epub 2017 Aug 12. Transl Oncol. 2017. PMID: 28806712 Free PMC article.

2

[Value of magnetic resonance imaging in diagnosing breast lesions which need biopsy].

Ling H, Gu YJ, Wang XH, Liu GY, Huang O, Wang LP, Shen KW, Shen ZZ. Ling H, et al. Zhonghua Wai Ke Za Zhi. 2006 Aug 1;44(15):1036-9. Zhonghua Wai Ke Za Zhi. 2006. PMID: 17074240 Chinese.

3

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM. Cao AY, et al. Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27. Ann Surg Oncol. 2012. PMID: 22451233

4

Efficacy and safety of docetaxel combined with oxaliplatin as a neoadjuvant chemotherapy regimen for Chinese triple-negative local advanced breast cancer patients. A prospective, open, and unicentric Phase II clinical trial.

Fei F, Chen C, Xue J, Di GH, Lu JS, Liu GY, Shao ZM, Wu J. Fei F, et al. Am J Clin Oncol. 2013 Dec;36(6):545-51. doi: 10.1097/COC.0b013e31825d5317. Am J Clin Oncol. 2013. PMID: 22868245 Clinical Trial.

5

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes.

Cao AY, He M, DI GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM. Cao AY, et al. Exp Ther Med. 2011 Sep;2(5):917-923. doi: 10.3892/etm.2011.275. Epub 2011 May 26. Exp Ther Med. 2011. PMID: 22977598 Free PMC article.

6

Performance of breast cancer screening methods and modality among Chinese women: a report from a society-based breast screening program (SBSP) in Shanghai.

Mo M, Liu GY, Zheng Y, Di LF, Ji YJ, Lv LL, Chen YY, Peng WJ, Zhu JR, Bao PP, Ding JH, Chang C, Luo JF, Cao ZG, Xu WH, Shao ZM. Mo M, et al. Springerplus. 2013 Jun 24;2(1):276. doi: 10.1186/2193-1801-2-276. eCollection 2013. Springerplus. 2013. PMID: 23961381 Free PMC article.

7

The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

Li JJ, Chen C, Gu Y, Di G, Wu J, Liu G, Shao Z. Li JJ, et al. Among authors: liu g. PLoS One. 2014 Feb 11;9(2):e88853. doi: 10.1371/journal.pone.0088853. eCollection 2014. PLoS One. 2014. PMID: 24523942 Free PMC article. Clinical Trial.

8

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy.

Li J, Chen S, Chen C, Di G, Liu G, Wu J, Shao Z. Li J, et al. Among authors: liu g. Oncotarget. 2017 Mar 14;8(11):18399-18408. doi: 10.18632/oncotarget.9369. Oncotarget. 2017. PMID: 27191991 Free PMC article.

9

Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer.

You C, Gu Y, Peng W, Li J, Shen X, Liu G, Peng W. You C, et al. Among authors: liu g. Acta Radiol. 2018 Jul;59(7):806-812. doi: 10.1177/0284185117738560. Epub 2017 Oct 24. Acta Radiol. 2018. PMID: 29065702

10

Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography.

Zhi W, Liu G, Chang C, Miao A, Zhu X, Xie L, Zhou J. Zhi W, et al. Among authors: liu g. Transl Oncol. 2018 Feb;11(1):56-64. doi: 10.1016/j.tranon.2017.10.011. Epub 2017 Nov 22. Transl Oncol. 2018. PMID: 29175630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,513 results

Search Page

Filters